
Share
CMS's six-month moratorium on new hospice and home health providers ends November 13, but the oversight it enabled isn't disappearing. It's shifting to claim-by-claim scrutiny, and small agencies will feel it first.
For six months, families searching for a trustworthy home health agency or hospice provider have had fewer new options to vet, because there haven't been many new agencies to vet at all. On May 13, CMS stopped enrolling new hospices and home health agencies nationwide, along with new branch locations and certain ownership changes. That kind of pause, known as a moratorium, legally lasts six months unless CMS extends it. The scheduled end is November 13.
CMS says the closed door has worked. A senior official said this fall that about 250 home health agencies and 50 hospices were denied enrollment in the first five months of the freeze. That's a real number, and it likely reflects real fraud prevented. But a moratorium is a blunt instrument. It stops bad actors from getting in the door, but it does nothing about the agencies already inside. And it was never designed to stay shut forever.
So what comes next? The evidence points toward a quieter, more granular kind of oversight: reviewing individual claims rather than blocking entire categories of new enrollment.
On November 2, CMS announced plans to expand the home health Review Choice Demonstration, known as RCD, to California, with billing periods starting on or after January 18, 2027, pending approval of the paperwork involved. California agencies will choose between pre-claim review and postpayment review during a window from November 16 to December 16, with postpayment review as the default if no choice is made. California would join Illinois, Ohio, Texas, North Carolina, Florida and Oklahoma in the program. An industry association leader told McKnight's Home Care that CMS may lean on tools like RCD as a substitute for broad moratoriums going forward.
Hospice oversight is moving in the same direction. In June, HHS's Office of Inspector General estimated that Medicare could have saved $255.1 million on hospice services for certain new enrollees. The OIG reviewed a sample of 100 initial certification periods and found that 45 didn't meet Medicare requirements. Of those, 21 lacked clinical support for a terminal prognosis, and 24 had documentation problems. The OIG recommended that contractors consider prepayment or postpayment review for this group of new hospice enrollees, and CMS agreed.
Think of the enrollment freeze as a locked front door and claim review as a security guard checking IDs at every desk inside the building. The door may reopen on November 13. The guard isn't going anywhere. If you run an agency, the months of the moratorium were the time to get your internal policies to actually match what your staff does day to day. That advice doesn't have an expiration date.
Pre-claim review isn't purely punitive, either. An agency gets an answer before it bills, not a clawback years down the road after the money's already been spent on payroll and patient care. CMS data for fiscal year 2024 show that 97% of home health pre-claim review requests in demonstration states were affirmed. Agencies that maintain a 90% affirmation rate can earn relief from most reviews, aside from occasional spot checks. Treat prior authorization like a free pre-audit: a reviewer grading your paperwork before you deliver care, with CMS rewarding the agencies that pass.
But the same data reveal where the friction lives. Of claims that went through prepayment or postpayment review, 84.4% were approved. Of denied claims that were appealed, 51.6% were overturned at the first level, most often because additional documentation surfaced that hadn't been submitted during the initial review, according to CMS.
That statistic is hard to shake. When half of appealed denials get reversed simply because a missing record finally appears, it suggests the problem often isn't fraud. It's communication. Clearer expectations up front could have saved an enormous amount of administrative labor on both sides. Ask yourself: does the chart actually support the claim? And when did anyone last pull ten charts and compare them against what Medicare actually paid?

A large health system treats an appeal as a routine cost of doing business, something absorbed by a dedicated compliance department. A small agency with a handful of office staff doesn't have that cushion. Every hour spent chasing a physician's signature or a missing face-to-face note is an hour not spent coordinating care for a dying patient or a homebound senior.
Fraud in these programs is real, and oversight is justified. But most people running into trouble aren't villains. Some cases involve greed, certainly. A lot more involve someone rushing to start a business and keep it afloat financially, cutting corners on documentation without intending to defraud anyone.
Expanded review doesn't land evenly across the industry. Agencies with the thinnest office capacity feel the weight of it first. If cash flow slows or denials pile up, some agencies may grow cautious about admitting complex, high-need patients. Others may close altogether. The patients who lose out in that scenario are often the ones who were hardest to serve to begin with, the ones with complicated diagnoses or unstable housing who need a hospice or home health team willing to take them on.
None of this is an argument against review. It's an argument for review that catches bad actors without grinding down the good ones.
Fairness starts with documentation standards an agency can actually locate and understand. Owners should be able to see in one place exactly what a reviewer expects regarding homebound status, face-to-face encounters and terminal prognosis documentation. Contractors already send each agency a decision letter explaining the reasons for a non-affirmation, along with education on common errors, according to the RCD operational guide. Those lessons should be made public, so agencies can learn from others' mistakes before they submit a claim, not after they've been denied one.
CMS could also publish the top reasons for non-affirmations and denials, broken out by state and contractor, alongside its existing yearly statistics. That transparency would reveal whether problems cluster around specific documentation requirements or specific contractors, and whether review is actually targeting high-risk providers rather than sweeping up everyone indiscriminately.
Access deserves equal billing with program integrity. As RCD and hospice review expand, CMS should track and report whether patients are waiting longer for home health to start or hospice admissions to be approved. Savings generated from denied claims tell only half the story. The other half is whether people got the care they needed, when they needed it.
Agencies have their own homework. Compliance can't be a binder pulled out once a year for an audit. It belongs in the weekly staff meeting, right next to the performance metrics everyone already tracks. Keep a running log of every review request and every decision, so your own team spots patterns before a contractor does. That habit is what lets an owner sleep at night when the next document request lands in the inbox.
CMS is accepting public comments on the California information collection through November 16, a narrow window for providers, patient advocates and families to weigh in on what fair review should look like. Enrollment freezes generate headlines because they're dramatic and absolute. The quieter rules that follow, the review windows, the documentation checklists, the appeal statistics, will shape the actual experience of patients and caregivers for years after the freeze is forgotten.
Tags
Original Sources
When the Enrollment Freeze Ends, Claim Review Takes Over — Small Providers Need Clear Rules - MedCity News
↗ https://medcitynews.com/2026/11/when-the-enrollment-freeze-ends-claim-review-takes-over-small-providers-need-clear-rules
About the author
Amara's entry point into AI was an epidemiology role at a London research hospital, where she spent five years studying how digital health tools reached — or conspicuously failed to reach — underserved communities. Watching early algorithmic systems in healthcare quietly entrench existing inequalities, she redirected her career toward the systemic consequences of AI at scale. She covers AI through an unflinching lens: who benefits, who bears the cost, and what evidence actually says versus what the press release claims. Her writing is calm and precise, but she doesn't mistake balance for neutrality.
More from The Steward →This Week's Edition
13 November 2026
14 articles
Related Articles

Europe's Digital ID Push Tests a New Privacy Tool: Zero-Knowledge Proofs
Policy & Regulation · 5 min

Why the Woman Who Fired Sam Altman Still Doesn't Trust AI's Boardrooms
Policy & Regulation · 5 min

Pakistan to Send Climate Minister to India for First High-Level Visit in Three Years
Policy & Regulation · 5 min
Related Articles

Europe's Digital ID Push Tests a New Privacy Tool: Zero-Knowledge Proofs
Policy & Regulation · 5 min

Why the Woman Who Fired Sam Altman Still Doesn't Trust AI's Boardrooms
Policy & Regulation · 5 min

Pakistan to Send Climate Minister to India for First High-Level Visit in Three Years
Policy & Regulation · 5 min
More Stories
© 2026 Cedar & Bloom. All rights reserved.